SMARTag™ ADC Technology | Catalent in 90 Seconds

Home » Expert Content » Category: "Biologics Development" SMARTag™ ADC Technology | Catalent in 90 Seconds Summary: SMARTag™ ADC technology enables biologic innovators to develop more efficacious antibody drug conjugates. This new...

Biologics Development Overview | Why Catalent?

Home » Expert Content » Category: "Biologics Development" Biologics Development Overview | Why Catalent? Summary: Our mission is to enable better biologic therapies to get to patients. Through our suite of proprietary technology...

Biosimilars | Why Catalent?

Home » Expert Content » Category: "Biologics Development" Biosimilars | Why Catalent? Summary: As your strategic partner for Biosimiliar development, our unique technologies and integrated services will help you to get more and better...

SMARTag™ Antibody Drug Conjugate Technology | Why Catalent?

Home » Expert Content » Category: "Biologics Development" SMARTag™ Antibody Drug Conjugate Technology | Why Catalent? Summary: The SMARTag™ Antibody Drug Conjugate technology platform offers ADC developers a new toolkit to develop...

SMARTag Technology: Better Conjugates

Home » Expert Content » Category: "Biologics Development" SMARTag Technology: Better Conjugates Summary: Jennifer Mitcham describes how Catalent’s SMARTag technlogy combines the targeted binding specificity and half-life benefits...

What are the latest development for SMARTag ADC technology?

Home » Expert Content » Category: "Biologics Development" What are the latest development for SMARTag ADC technology? Summary: Antibody drug conjugates (ADCs) combine the targeted binding specificity and half-life benefits of monoclonal...